Literature DB >> 4379173

Two types of 5-hydroxytryptamine release from isolated blood platelets.

G Bartholini, A Pletscher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1964        PMID: 4379173     DOI: 10.1007/bf02147970

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  5 in total

1.  DECREASE OF CEREBRAL 5-HYDROXYTRYPTAMINE AND 5-HYDROXYINDOLACETIC ACID BY AN ARYLALKYLAMINE.

Authors:  A PLETSCHER; W P BURKARD; H BRUDERER; K F GEY
Journal:  Life Sci (1962)       Date:  1963-11

2.  Metabolism of norepinephrine-H3 released by tyramine and reserpine.

Authors:  I J KOPIN; E K GORDON
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

3.  Studies on the storage of norepinephrine and the effect of drugs.

Authors:  L T POTTER; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1963-05       Impact factor: 4.030

4.  Diminution of 5-hydroxytryptamine in thrombocytes in vitro by chlorpromazine and related compounds.

Authors:  G BARTHOLINI; A PLETSCHER; K F GEY
Journal:  Experientia       Date:  1961-12-15

5.  Identification and assay of serotonin in brain.

Authors:  D F BOGDANSKI; A PLETSCHER; B B BRODIE; S UNDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

  5 in total
  11 in total

1.  The effects of serotonergic and antiserotonergic drugs on the flexor reflex of spinal rat: a proposed model to evaluate the action on the central serotonin receptor.

Authors:  J Maj; W Palider; L Baran
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

Review 2.  Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets.

Authors:  A Pletscher
Journal:  Br J Pharmacol Chemother       Date:  1968-01

3.  The action of calcium and thrombin on isolated 5-hydroxytryptamine organelles of blood platelets.

Authors:  A Pletscher; M Da Prada; J P Pranzer
Journal:  Experientia       Date:  1968-12-15

4.  Identification of guanosine 5'-triphosphate and uridine 5'-triphosphate in subcellular monamine-storage organelles.

Authors:  M da Prada; A Pletscher
Journal:  Biochem J       Date:  1970-08       Impact factor: 3.857

5.  Formation of 5-hydroxytryptophol by blood platelets after thrombin and reserpine.

Authors:  M da Prada; G Bartholini; A Pletscher
Journal:  Experientia       Date:  1965-03-15

6.  [On the occurrence of 5-hydroxyindolacetic acid in the human brain].

Authors:  H Bernheimer
Journal:  Klin Wochenschr       Date:  1965-10-15

7.  Antidepressants and anti-inflammatory drugs differentially reduce the release of NGF and BDNF from rat platelets.

Authors:  T Hochstrasser; D Ehrlich; B Sperner-Unterweger; C Humpel
Journal:  Pharmacopsychiatry       Date:  2012-06-14       Impact factor: 5.788

8.  5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets.

Authors:  H R Baumgartner
Journal:  J Physiol       Date:  1969-04       Impact factor: 5.182

9.  The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.

Authors:  G Rudnick; S C Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

10.  An assessment of platelet aggregation induced by 5-hydroxytryptamine.

Authors:  B P Hilton; J N Cumings
Journal:  J Clin Pathol       Date:  1971-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.